# GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
Canonical URL: https://biopharmsignal.com/news/WGS/genedx-to-report-fourth-quarter-2023-financial-results-on-tuesday-february-20-20-206af31f
Ticker: WGS
Company: GeneDx
Source: GeneDx
Published: 2024-02-01 21:30 EST
## Summary

GeneDx management will host a conference call at 4:30 p.m. Eastern Time on February 20, 2024 to discuss 2023 results and share full year 2024 guidance....

## Article Body
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced it will release financial results for the fourth quarter of 2023 after the market closes on Tuesday, February 20, 2024. Management will host a conference call that day to discuss 2023 financial and operating results and share full year 2024 guidance at 4:30 p.m. Eastern Time.

Conference Call Details Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the “Events” section of the GeneDx investor relations website at https://ir.genedx.com/ .

About GeneDx GeneDx (Nasdaq: WGS) delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by one of the world’s largest rare disease data sets. For more information, please visit www.genedx.com and connect with us on LinkedIn , Facebook , Twitter and Instagram .

Investor Relations Contact: investors@GeneDx.com

Media Contact: press@GeneDx.com
## Recent Company News
- 2024-07-11 20:05 EST — [GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024](https://biopharmsignal.com/news/WGS/genedx-to-report-second-quarter-2024-financial-results-on-tuesday-july-30-2024-4818bc73) — Source: GeneDx
- 2024-06-10 12:30 EST — [GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients](https://biopharmsignal.com/news/WGS/genedx-announces-collaboration-with-epic-aura-to-expand-access-to-rapid-whole-ge-740de912) — Source: GeneDx
- 2024-06-05 11:00 EST — [GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients](https://biopharmsignal.com/news/WGS/genedx-announces-patient-access-program-to-expand-access-to-exome-testing-for-pe-c4b289d2) — Source: GeneDx
- 2024-05-22 20:05 EST — [GeneDx to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/WGS/genedx-to-participate-in-upcoming-investor-conferences-5e6d9364) — Source: GeneDx
- 2024-04-29 20:05 EST — [GeneDx Reports First Quarter 2024 Financial Results and Business Highlights](https://biopharmsignal.com/news/WGS/genedx-reports-first-quarter-2024-financial-results-and-business-highlights-6b87f4af) — Source: GeneDx
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)